The Outcome of Prostate Cancer Screening in a Normal Japanese Population with PSA of 2-4 ng/ml and the Free/Total PSA Under 12%
Shigeto Ishidoya(Sendai City Hospital), Yoichi Arai(Japan Atomic Energy Agency), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Tadashi Tsukamoto(Broad Institute), Masaaki Kuwahara(Tohoku University), Kazuhiko Orikasa(Sendai Shakai Hoken Hospital), Daisuke Shibuya, Naoya Masumori(Sapporo Medical University), Takuya Yamanobe(Yamagata University), Yoshihiko Tomita(Niigata University Medical and Dental Hospital), Taro Tochigi(Miyagi Prefectural Hospital Organization), Akihiro Ito(Tohoku University)
Cited by 12
Related Papers
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253
ANATOMICAL ANALYSIS OF THE NEUROVASCULAR BUNDLE SUPPLYING PENILE CAVERNOUS TISSUE TO ENSURE A RELIABLE NERVE GRAFT AFTER RADICAL PROSTATECTOMY
|The Journal of Urology|2004|159
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
|The Journal of Urology|1990|122
Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
|Annals of Surgery|2009|121
Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility
|Journal of Biological Chemistry|2006|116